Skip to main content

Wesley Hospital Pulmonary Hypertension Unit

The information available in this section was provided by each healthcare professional. If you need more information, please contact the healthcare professional directly.

Clinic Details

Dr John Feenstra
Dr Chris Zappala
Rebekka Beaumont (Nurse)
Operating Hours

-27.4772064, 152.9977882

Suite 70, Level 3 30 Chasely St
Auchenflower 4066 QLD


Dr John Feenstra, Nurse: Rebekka Beaumont

Dr Feenstra is also the lead Physician at The Prince Charles Hospital (TPCH) working in the Pulmonary Vascular Disease Service, adding to his experience and expertise in treating patients with PAH and CTEPH. TPCH is an active trial site for various studies in PAH and CTEPH.

Hospital Information

The Wesley Pulmonary Hypertension Unit is a private referral-based service that began at the Wesley in 2008. Located in the Sandford Jackson Building on The Wesley Hospital campus, the unit assists patients suspected of having Pulmonary Arterial Hypertension and/or Chronic Thromboembolic Pulmonary Hypertension (CTEPH), and co-ordinates their treatment. Pulmonary arterial hypertension is a relatively uncommon disease of the pulmonary arteries that is characterised by a progressive increase in pulmonary vascular resistance. This basically means that the right ventricle of the heart gradually becomes overloaded which leads to right ventricular failure and a premature death. The Wesley Pulmonary Hypertension Unit is an expert service, providing education on the disease and available treatments to their patients and complete regular patient assessments to monitor their medication and progress. The unit also works in conjunction with the Wesley Research Institute in trials to help improve access to various medications for PAH and CTEPH.

Janssen-Cilag Pty Ltd, is proud to be a partner of PHSANZ in supporting education & research in the pulmonary hypertension field. PHSANZ is the professional society focused on facilitating research and educating members on the diagnosis and treatment of pulmonary hypertension. Their members include respiratory physicians, cardiologists, rheumatologists, immunologists, nurses and allied health professionals. If you would like more information about PHSANZ, please visit their site on this link.


Copyright © 2019 Janssen-Cilag Pty Ltd


Janssen-Cilag Pty Ltd
ACN 000 129 975. 1-5 Khartoum Rd Macquarie Park NSW 2113, Australia.
Telephone: 1800 226 334
Date of Prep: September 2020 CP-140515


Janssen-Cilag Pty, Ltd, all rights reserved.